Half-life
~30–60 minutes based on preclinical data
Mechanism of Action
Activates AMPK pathway, regulates the folate cycle, and modulates metabolic flexibility. Functions as a mitochondrial "hormone" signaling cellular stress and energy status.
Published Research Ranges & Study Context
Studies have administered: Primarily preclinical; 0.1–5mg/kg in animal studies; human trials underway
Important Research Framing
These are ranges reported in published scientific studies. They are provided for educational context only and do not constitute dosing recommendations. Individual study parameters vary by design, population, and research objectives. This information is not medical advice.
Primary Research Findings
Animal studies show improved insulin sensitivity, enhanced exercise capacity, and extended lifespan in aging models. First human phase 1 study published 2021.
Emerging
Early-stage research — limited human data
Side Effects Observed in Research
Not well-characterized in human studies; preclinical data favorable
Available Configurations (SKU Reference)
MS10
MS40
Compounds Studied in Combination
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on MOTS-c — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat
Research Education Only: This compound profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions. Regulatory status varies by jurisdiction.